ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Asston Pharmaceuticals Limited announced its Annual General Meeting scheduled for September 29, 2026. The agenda includes adopting financial statements, appointing auditors, and revising remuneration for key managerial personnel.
Asston Pharmaceuticals held an EGM on July 31, 2026. Shareholders approved a special resolution to issue equity shares on a preferential basis.
Asston Pharmaceuticals convened an EGM for July 31, 2026. Shareholders will vote on a special resolution to issue equity shares on a preferential basis.
Asston Pharmaceuticals convened an EGM for July 31, 2026. The agenda includes a Rs. 27.72 Crore preferential allotment of 24.10 lakh equity shares.
Asston Pharmaceuticals Limited conducted an Extraordinary General Meeting on April 28, 2026, via video conferencing. Shareholders considered resolutions including the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of three directors. The meeting concluded successfully with e-voting facilities provided to members.
Asston Pharmaceuticals Limited announced the voting results of its Extraordinary General Meeting held on April 28, 2026. Shareholders approved the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of three directors. All resolutions were passed with 100% of the votes cast in favour.